Recent Updates
Recently added Catalysts
BIIB

FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union

Key Takeaway: FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union

Full Press Release Details

FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union.
Last updated: May 30, 2016